glp 1 patches vs shot Things to Know About GLP-1 GLP-1 Patches vs. GLP-1 Injections:

Am J Cardiovasc Drugs

In August 2025, the FDA approved Wegovy to treat MASH, also known as nonalcoholic steatohepatitis, in adults with moderate to advanced fibrosis

Reduced risks were noted for cancers of the digestive (HR 0.81), respiratory (HR 0.66), and female genital (HR 0.87) systems

They are not approved by the FDA and are not intended for human or veterinary use, clinical applications, diagnostic procedures, or therapeutic treatment of any kind

These compounds are not FDA-approved, so their manufacturing lacks the rigorous safety, labeling and oversight that patients deserve and expect

Other red flags: uncontrollable vomiting , inability to keep fluids down, worsening weakness or dehydration